An open-label, multicentre study of levocetirizine for the treatment of allergic rhinitis and Urticaria in Taiwanese Patients

Chinese Journal of Physiology

Volumn 53, Issue 4, 2010, Pages 199-207

  Fang, Sheen Yie ^a,b   Perng, Diahn Warng ^c,d   Lee, J Yu Yun ^e   Lin, Ding Yu ^f   Huang, Chih Yang ^f,g  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b Chiali Medical Corporation Aggregate Chiali Hospital   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

Author keywords

Allergic rhinitis; Intermittent allergic rhinitis; Levocetirizine; Patient perception; Persistent allergic rhinitis; Urticaria

Indexed keywords

LEVOCETIRIZINE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHENIA; ASTHMA; CLINICAL TRIAL; CONCEPT FORMATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTPATIENT; PATIENT SATISFACTION; PRURITUS; SLEEP TIME; SOMNOLENCE; SYMPTOMATOLOGY; TAIWAN; URTICARIA; XEROSTOMIA;

EID: 78149419354     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2010.AMK007     Document Type: Article

References (33)

1. Bachert, C., Bousquet, J., Canonica, G.W., Durham, S.R., Klimek, L., Mullol, J., Van Cauwenberge, P.B. and Van Hammée, G.; XPERT Study Group. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J. Allergy Clin. Immunol. 114: 838-844, 2004.
2. Bachert, C., Van Cauwenberge, P., Olbrecht, J. and Van Schoor, J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 61: 693-698, 2006.
3. Bauchau, V. and Durham, S.R. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 60: 350-353, 2005.
4. Bauchau, V. and Durham, S.R. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur. Respir. J. 24: 758-764, 2004.
5. Bateman, E.D., Hurd, S.S., Barnes, P.J., Bousquet, J., Drazen, J.M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S.E., Pizzichini, E., Sullivan, S.D., Wenzel, S.E. and Zar, H.J. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 31: 143-178, 2008.
6. Bousquet, J., Annesi, Maesano, I., Carat, F., Léger, D., Rugina, M., Pribil, C., El, Hasnaoui A. and Chanal, I.; DREAMS study group. Characteristics of intermittent and persistent allergic rhinitis. Clin. Exp. Allergy 35: 728-732, 2005.
7. Bousquet, J., Neukirch, F., Bousquet, P.J., Gehano, P., Klossek, J.M., Le, Gal M. and Allaf, B. Severity and impairment of allergic rhinitis in patients consulting in primary care. J. Allergy Clin. Immunol. 117: 158-162, 2006.
8. Bousquet, J., Van Cauwenberge, P. and Khaltaev, N. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 108 Suppl. 5: S147-S334, 2001.
9. Canonica, G.W., Bousquet, J., Van Hamme, G., Bachert, C., Durham, S.R., Klimek, L., Mullol, J. and Van Cauwenberge, P.B. The XPERT study group. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir. Med. 100: 1706-1715, 2006.
10. De, Blic J., Wahn, U., Billard, E., Alt, R. and Pujazon, M.C. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr. Allergy Immunol. 16: 267-275, 2005.
11. Demoly, P., Allaert, F.A., Lecasble, M., Bousquet, J. and PRAGMA. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 58: 672-675, 2003.
12. Greaves, M.W. Chronic idiopathic urticaria. Curr. Opin. Allergy Clin. Immunol. 3: 363-368, 2003.
13. Jorissen, M., Bertrand, B., Stiels, B. and Vandenbulcke, K. Levocetirizine as treatment for symptoms of seasonal allergic rhinitis. B-ENT [Publication of the Royal Belgian Society for ENT (otolaryngology) and Head and Neck Surgery] 2: 55-62, 2006.
14. Kapp, A. and Pichler, W.J. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. Int. J. Dermatol. 45: 469-474, 2006.
15. Klimek, L. and Hundorf, I. Levocetirizine in allergic diseases: An open multicentre practice study of efficacy and tolerability. Allergologie 25 Suppl. 1: S1-S7, 2002.
16. Klimek, L., Wrede, H., Schott, B.C. and Hansen, I. Patients' perception of the value of levocetirizine in allergic diseases. Clin. Drug Invest. 25: 609-614, 2005.
17. Kozel, M.M.A. and Sabroe, R.A. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 64: 2515-2536, 2004.
18. Leynadier, F., Mees, K., Arendt, C. and Pinelli, M.E. Efficacy and safety of levocetirizine in seasonal allergic rhinitis. Acta Otorhinolaryngol. Belg. 55: 305-312, 2001.
19. Leynaert, B., Neukirch, C., Liard, R., Bousquet, J. and Neukirch, F. Quality of life in allergic rhinitis and asthma. A population based study of young adults. Am. J. Respir. Crit. Care Med. 162: 1391-1396, 2000.
20. Mösges, R. and Klimek. Today's allergic rhinitis patients are different: new factors that may play a role. Allergy 62: 969-975, 2007.
21. Nettis, E., Colanardi, M.C., Barra, L., Ferrannini, A., Vacca, A. and Tursi, A. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Br. J. Dermatol. 154: 533-538, 2006.
22. Pfaar, O., Wrede, H., Barth, C., Hansen, I. and Klimek, L. Levocetirizine in patients with chronic idiopathic urticaria: results of a multicenter clinical practice study. Int. J. Clin. Pharmacol. Ther. 44: 191-192, 2006.
23. Poon, E., Seed, P.T., Greaves, M.W. and Kobza, Black, A. The extent and nature of disability in different urticarial conditions. Br. J. Dermatol. 140: 667-671, 1999.
24. Potter, P.C. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Ann. Allergy Asthma Immunol. 95: 175-180, 2005.
25. Potter, P.C. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy 58: 893-899, 2003.
26. Schoenwetter, W.F., Dupclay, L., Appajosyula, S., Botteman, M.F. and Pashos, C.L. Economic impact and quality of life burden of allergic rhinitis. Curr. Med. Res. Opin. 20: 305-317, 2004.
27. Settipane, R.A. and Lieberman, P. Update on nonallergic rhinitis. Ann. Allergy Asthma Immunol. 86: 494-507, 2001.
28. Thompson, A.K., Juniper, E. and Meltzer, E.O. Quality of life in patients with allergic rhinitis. Ann. Allergy Asthma Immunol. 85: 338-347, 2000.
29. Todo-Bom, A., Loureiro, C., Almeida, M.M., Nunes, C., Delgado, L., Castel-Branco, G. and Bousquet, J. Epidemiology of rhinitis in Portugal: evaluation of the intermittent and the persistent types. Allergy 62: 1038-1043, 2007.
30. Van Cauwenberge, P., Bachert, C., Passalacqua, G., Bousquet, J., Canonica, G.W., Durham, S.R., Fokkens, W.J., Howarth, P.H., Lund, V., Malling, H.J., Mygind, N., Passali, D., Scadding, G.K. and Wang, D.Y. Consensus statement on the treatment of allergic rhinitis. Allergy 55: 116-134, 2000.
31. Van Hoecke, H., Vastesaeger, N., Dewulf, L., Sys, L. and Van Cauwenberge, P. Classification and management of allergic rhinitis patients in general practice during pollen season. Allergy 61: 705-711, 2006.
32. Yin, O.Q., Shi, X.J., Tomlinson, B. and Chow, M.S. Effect of CYP2D6*10 allele on the pharmacokinetics of loratadine in Chinese subjects. Drug Metab. Dispos. 33: 1283-1287, 2005.
33. Zuberbier, T., Bindslev-Jensen, C., Canonica, W., Grattan, C.E., Greaves, M.W., Henz, B.M., Kapp, A., Kozel, MMA., Maurer, M., Merk, H.F., Schäfer, T., Simon, D., Vena, G.A. and Wedi, B. EAACI/GA2LEN/EDF. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy 61: 321-331, 2006.